Om­nibus spend­ing bill fea­tures fund­ing to bol­ster the sup­ply chain and site in­spec­tions

Af­ter com­mit­ting about $2 bil­lion for new bio­man­u­fac­tur­ing ef­forts, next year’s $1.7 tril­lion gov­ern­ment spend­ing bill fea­tures new phar­ma man­u­fac­tur­ing ef­forts.

In ad­di­tion to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.